Hedge Funds are Betting on These 5 Sliding Stocks

3. Bristol Myers Squibb Company (NYSE:BMY)

Number of Hedge Fund Holders: 65

Bristol Myers Squibb Company (NYSE:BMY) shares have lost a whopping 30% year to date through December 4. Last month, Reuters reported that the FDA approved Bristol Myers Squibb Company (NYSE:BMY)’s drug repotrectinib for the treatment of a type of non-small cell lung cancer.

As of the end of the third quarter of 2023, 65 hedge funds reported owning stakes in Bristol Myers Squibb Company (NYSE:BMY).